Research-informed health explainers
Plain-language guides to conditions, treatments, and medications — each one grounded in peer-reviewed research from the specialists in our directory.
18 articles in Endocrinology · Page 2 of 2
SELECT Trial: Semaglutide and Heart Attack Risk
What the SELECT trial showed about semaglutide reducing heart attacks, strokes, and cardiovascular death in people with obesity but no diabetes.
Ildiko Lingvay, MD · Anne Peters, M.D. · Janet McGill, MD
Semaglutide vs Tirzepatide: Diabetes and Weight Loss
How semaglutide and tirzepatide compare for type 2 diabetes and weight loss: A1c reduction, weight outcomes, cardiovascular data, and when each is the better choice.
Ildiko Lingvay · Bruce Bode · Kathleen Dungan · John Buse
Semaglutide vs tirzepatide for weight loss
Comparing semaglutide and tirzepatide for weight loss: what the clinical trials show, who each drug is typically for, and what to ask your doctor.
Ildiko Lingvay · John Buse · Caroline Apovian
Total vs Partial Thyroidectomy for Graves Disease
Evidence-based comparison of total and partial thyroidectomy for Graves disease: cure rates, recurrence risk, complications, and when each approach is recommended.
Marius Stan, M.D. · Giuseppe Barbesino, MD · Ellen Marqusee, MD · Megan Haymart, M.D.
Transsphenoidal vs Craniotomy for Pituitary Tumor
For most pituitary tumors, transsphenoidal surgery through the nose is the standard approach. Craniotomy is reserved for specific cases. Here is what the evidence shows.
Beverly Biller, MD · Laurence Katznelson, MD · Maria Fleseriu, MD · Baha Arafah, MD
Weight Regain After Stopping GLP-1: What to Expect
Most people regain significant weight after stopping GLP-1 medications. Here is what the evidence shows, why it happens, and how to reduce regain.
Ildiko Lingvay, MD · Anne Peters, M.D. · Janet McGill, MD